202 related articles for article (PubMed ID: 33419896)
1. Impact of
Pasvenskaite A; Liutkeviciene R; Gedvilaite G; Vilkeviciute A; Liutkevicius V; Uloza V
Cancer Genomics Proteomics; 2021; 18(1):53-65. PubMed ID: 33419896
[TBL] [Abstract][Full Text] [Related]
2. Association of SIRT1 single gene nucleotide polymorphisms and serum SIRT1 levels with laryngeal squamous cell carcinoma patient survival rate.
Vaiciulis P; Liutkeviciene R; Liutkevicius V; Vilkeviciute A; Gedvilaite G; Uloza V
Cancer Biomark; 2022; 34(2):175-188. PubMed ID: 34719479
[TBL] [Abstract][Full Text] [Related]
3. The association of E2F1 and E2F2 single nucleotide polymorphisms with laryngeal squamous cell carcinoma pathomorphological features.
Jakstas T; Bartnykaite A; Padervinskis E; Vegiene A; Juozaityte E; Uloza V; Ugenskiene R
BMC Cancer; 2024 Feb; 24(1):214. PubMed ID: 38360622
[TBL] [Abstract][Full Text] [Related]
4. The Role of
Pasvenskaite A; Liutkeviciene R; Gedvilaite G; Vilkeviciute A; Liutkevicius V; Uloza V
Cells; 2021 Mar; 10(3):. PubMed ID: 33803218
[TBL] [Abstract][Full Text] [Related]
5. Expression levels of SCCA and CYFRA 21-1 in serum of patients with laryngeal squamous cell carcinoma and their correlation with tumorigenesis and progression.
Ji M; Zhang LJ
Clin Transl Oncol; 2021 Feb; 23(2):289-295. PubMed ID: 32577996
[TBL] [Abstract][Full Text] [Related]
6. Associations of Polymorphisms Localized in the 3'UTR Regions of the
Insodaite R; Smalinskiene A; Liutkevicius V; Ulozas V; Poceviciute R; Bielevicius A; Kucinskas L
Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828284
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of neuropilin-2 expression in laryngeal squamous cell carcinoma.
Yin D; Guo L; Li S; Tuerdi A; Yang X; Tang Q; Wang S; Liu J; Huang P; Li M
Am J Otolaryngol; 2020; 41(4):102540. PubMed ID: 32480134
[TBL] [Abstract][Full Text] [Related]
8. Associations of IL6 rs1800795, BLK rs13277113, TIMP3 rs9621532, IL1RL1 rs1041973 and IL1RAP rs4624606 single gene polymorphisms with laryngeal squamous cell carcinoma.
Pasvenskaite A; Vilkeviciute A; Liutkeviciene R; Gedvilaite G; Liutkevicius V; Uloza V
Gene; 2020 Jul; 747():144700. PubMed ID: 32330537
[TBL] [Abstract][Full Text] [Related]
9. The Role of ApoE Serum Levels and
Liutkeviciene R; Auzelyte J; Liutkevicius V; Vilkeviciute A; Gedvilaite G; Vaiciulis P; Uloza V
Biomolecules; 2022 Jul; 12(8):. PubMed ID: 35892323
[TBL] [Abstract][Full Text] [Related]
10. LncRNA SNHG20 promotes the development of laryngeal squamous cell carcinoma by regulating miR-140.
Li Y; Xu J; Guo YN; Yang BB
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3401-3409. PubMed ID: 31081112
[TBL] [Abstract][Full Text] [Related]
11. The PLCE1 rs2274223 variant is associated with the risk of laryngeal squamous cell carcinoma.
Zhang Y; Li W; Wang Y; Wang N
Int J Med Sci; 2020; 17(17):2826-2830. PubMed ID: 33162810
[No Abstract] [Full Text] [Related]
12. SIRT4 expression in laryngeal squamous cell carcinoma.
Wan W; Li Y; Zhou C; Sun B; Yang S; Zhou C
Pharmazie; 2020 Dec; 75(12):646-650. PubMed ID: 33303058
[TBL] [Abstract][Full Text] [Related]
13. Expression of vimentin (VIM) and metastasis-associated 1 (MTA1) protein in laryngeal squamous cell carcinoma are associated with prognostic outcome of patients.
Karamagkiolas S; Giotakis I; Kyrodimos E; Giotakis EI; Kataki A; Karagianni F; Lazaris AM
Am J Otolaryngol; 2019; 40(4):487-493. PubMed ID: 30979652
[TBL] [Abstract][Full Text] [Related]
14. DIRC3 and near NABP1 genetic polymorphisms are associated laryngeal squamous cell carcinoma patient survival.
Shen Z; Ren W; Bai Y; Chen Z; Li J; Li B; Jin T; Cao P; Shao Y
Oncotarget; 2016 Nov; 7(48):79596-79604. PubMed ID: 27793000
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expressed long non-coding RNAs in laryngeal squamous-cell carcinoma.
Li H; Wang FL; Li W; Fei YH; Wang YT; Zhang JE; Bi HY; Zhang M
Am J Otolaryngol; 2019; 40(5):615-625. PubMed ID: 31128861
[TBL] [Abstract][Full Text] [Related]
16. Association of the microsatellite (GT)n repeat polymorphisms of the HO-1 gene promoter and corresponding serum levels with the risk of laryngeal squamous cell carcinoma.
Tang D; Tang WJ; Shi XL; Li WP; Zhou H; Lu LM; Tao L
Acta Otolaryngol; 2016 Aug; 136(8):806-11. PubMed ID: 27400252
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of Epigenetic Signature Predict Survival for Patients with Laryngeal Squamous Cell Carcinoma.
Cui J; Wang L; Zhong W; Chen Z; Chen J; Yang H; Liu G
DNA Cell Biol; 2021 Feb; 40(2):247-264. PubMed ID: 33481663
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms as non-modifiable susceptibility factors to laryngeal cancer.
Escalante P; Barría T; Cancino M; Rahal M; Cerpa L; Sandoval C; Molina-Mellico S; Suárez M; Martínez M; Cáceres DD; Quiñones LA; Varela NM
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32338278
[TBL] [Abstract][Full Text] [Related]
19. Effects of interleukin-10 polymorphisms (rs1800896, rs1800871, and rs1800872) on breast cancer risk: evidence from an updated meta-analysis.
Dai ZJ; Wang XJ; Zhao Y; Ma XB; Kang HF; Min WL; Lin S; Yang PT; Liu XX
Genet Test Mol Biomarkers; 2014 Jun; 18(6):439-45. PubMed ID: 24720854
[TBL] [Abstract][Full Text] [Related]
20. Clinical value of serum HMGB1 in diagnosis and prognosis of laryngeal squamous cell carcinoma.
Qiu G; Li Y; Liu Z; Wang M; Ge J; Bai X
Med Oncol; 2014 Dec; 31(12):316. PubMed ID: 25373322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
